Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Patricia Shepherd"'
Autor:
Klaas J. Roozendaal, J.H. Frederik Falkenburg, Claire Chapman, Sue Richards, Saskia le Cessie, H. Berna Beverloo, Georgina Buck, Anthony R. Green, Hans van der Lelie, Alison E. Milne, David Bareford, Patricia Shepherd, Petra Muus, Tim Littlewood, Hanneke C. Kluin-Nelemans
Publikováno v:
Blood, 103, 4408-15
Blood, 103, 12, pp. 4408-15
Blood, 103(12), 4408-4415. American Society of Hematology
Blood, 103, 12, pp. 4408-15
Blood, 103(12), 4408-4415. American Society of Hematology
Item does not contain fulltext The optimal dose of interferon-alfa (IFN) for chronic myeloid leukemia (CML) is unknown. Retrospective analyses suggest that low doses are as effective as high doses, with less toxicity and fewer patients abandoning the
Autor:
Dietger Niederwieser, Thomas Friedrich, Michael W. Deininger, Christina Franke, Evelin Hennig, Thomas Bumm, Erika Schmidt, Knut Krohn, Patricia Shepherd, Christel Müller, R. Krahl, Sabine Leiblein, Haifa Kathrin Al-Ali
Publikováno v:
Blood. 101:1941-1949
Chronic myelogenous leukemia (CML) is characterized by the presence of a Bcr-Abl fusion protein with deregulated tyrosine kinase activity that is required for maintaining the malignant phenotype. Imatinib, a selective inhibitor ofBcr-Abl, induces maj
Autor:
Colin Grace, Anthony J. Bench, Alistair Reid, Brian J. P. Huntly, Elizabeth P. Nacheva, Nick Telford, Patricia Shepherd, Jeff Szer, Lynda J. Campbell, Henry Miles Prince, Anthony R. Green, P Turner
Publikováno v:
Blood. 98:1732-1738
Chronic myeloid leukemia (CML) is characterized by formation of the BCR-ABL fusion gene, usually as a consequence of the Philadelphia (Ph) translocation between chromosomes 9 and 22. Large deletions on the derivative chromosome 9 have recently been r
Autor:
James S. Wainscoat, Paul McGale, Patricia Shepherd, J Boultwood, Susan Richards, Andrew Peniket, Fiona Watkins, Carrie Fidler, Timothy Littlewood
Publikováno v:
Blood. 96:358-361
Telomere shortening is associated with disease evolution in chronic myelogenous leukemia (CML). We have examined the relationship between diagnostic telomere length and outcome in 59 patients with CML who entered into the MRC CMLIII Trial by Southern
Publikováno v:
Blood. 104:1021-1021
Stem cell transplantation (SCT) remains the only proven curative therapy for chronic myeloid leukemia (CML) but is limited by significant procedure related morbidity. Imatinib is the first of a new generation of specifically targeted drugs for this d
Autor:
Haifa-Kathrin, Al-Ali, Thomas, Bumm, Christel, Muller, Patricia, Shepherd, Niederwieser, Dietger, Knut, Krohn, Deininger, MichaelW. N *
Publikováno v:
In Blood 1 October 2003 102(7):2701-2701